HEADER HYDROLASE/HYDROLASE INHIBITOR 03-NOV-11 3UHL TITLE CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL TITLE 2 ISOLATE PR20 IN COMPLEX WITH P2-NC SUBSTRATE ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 501-599; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 GENE: POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.AGNISWAMY,S.CHEN-HSIANG,I.WEBER REVDAT 3 13-SEP-23 3UHL 1 REMARK SEQADV REVDAT 2 17-OCT-12 3UHL 1 JRNL REMARK REVDAT 1 28-MAR-12 3UHL 0 JRNL AUTH J.AGNISWAMY,C.H.SHEN,A.ANIANA,J.M.SAYER,J.M.LOUIS,I.T.WEBER JRNL TITL HIV-1 PROTEASE WITH 20 MUTATIONS EXHIBITS EXTREME RESISTANCE JRNL TITL 2 TO CLINICAL INHIBITORS THROUGH COORDINATED STRUCTURAL JRNL TITL 3 REARRANGEMENTS. JRNL REF BIOCHEMISTRY V. 51 2819 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 22404139 JRNL DOI 10.1021/BI2018317 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 20141 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2206 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1329 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : 0.3840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3034 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 106 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.47000 REMARK 3 B22 (A**2) : 1.47000 REMARK 3 B33 (A**2) : -2.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.271 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.223 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.571 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.890 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3189 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4333 ; 1.904 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 403 ; 8.142 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 120 ;40.659 ;24.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 554 ;21.117 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;14.346 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 503 ; 0.132 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2322 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1995 ; 0.846 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3253 ; 1.504 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1194 ; 2.489 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1077 ; 3.851 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 5 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 99 REMARK 3 RESIDUE RANGE : B 1 B 99 REMARK 3 RESIDUE RANGE : C 1 C 99 REMARK 3 RESIDUE RANGE : D 1 D 99 REMARK 3 RESIDUE RANGE : C 101 C 301 REMARK 3 ORIGIN FOR THE GROUP (A): 2.1929 -10.2252 -30.8497 REMARK 3 T TENSOR REMARK 3 T11: 0.2814 T22: 0.1312 REMARK 3 T33: 0.1928 T12: 0.0398 REMARK 3 T13: 0.0349 T23: 0.0196 REMARK 3 L TENSOR REMARK 3 L11: 0.9669 L22: 1.9164 REMARK 3 L33: 4.2949 L12: -0.6270 REMARK 3 L13: 1.3457 L23: -0.7473 REMARK 3 S TENSOR REMARK 3 S11: -0.2306 S12: -0.1773 S13: -0.0750 REMARK 3 S21: 0.5407 S22: 0.2816 S23: 0.1622 REMARK 3 S31: -0.0692 S32: -0.6726 S33: -0.0510 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TLS REFINEMENT REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 3UHL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000068764. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : SI 220 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23454 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.12500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2AOD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9M AMMONIUM SULFATE, 0.1M SODIUM REMARK 280 CITRATE, PH 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 106.83200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.89450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.89450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 160.24800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.89450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.89450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 53.41600 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.89450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.89450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 160.24800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.89450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.89450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 53.41600 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 106.83200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 514 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY B 51 N - CA - C ANGL. DEV. = -15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA C 67 80.46 38.95 REMARK 500 ARG D 8 130.35 -32.88 REMARK 500 ARG D 8 117.90 -10.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 49 ILE B 50 145.75 REMARK 500 ILE B 50 GLY B 51 -141.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-{(2S)-2-[(N-ACETYL-L-THREONYL-L-ISOLEUCYL)AMINO] REMARK 630 HEXYL}-L-NORLEUCYL-L-GLUTAMINYL-N~5~-[AMINO(IMINIO)METHYL]-L- REMARK 630 ORNITHINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 2NC C 101 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACE THR ILE 2A0 GLN ARG NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2NC C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3UCB RELATED DB: PDB REMARK 900 RELATED ID: 3UF3 RELATED DB: PDB REMARK 900 RELATED ID: 3UFN RELATED DB: PDB DBREF 3UHL A 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 3UHL B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 3UHL C 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 3UHL D 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 3UHL LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 3UHL PHE A 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 3UHL VAL A 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 3UHL VAL A 15 UNP P03367 ILE 515 ENGINEERED MUTATION SEQADV 3UHL ASN A 30 UNP P03367 ASP 530 ENGINEERED MUTATION SEQADV 3UHL ILE A 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 3UHL PHE A 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 3UHL ASP A 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 3UHL ILE A 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 3UHL ASN A 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 3UHL VAL A 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 3UHL LEU A 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 3UHL GLU A 58 UNP P03367 GLN 558 ENGINEERED MUTATION SEQADV 3UHL VAL A 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 3UHL PRO A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 3UHL ALA A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 3UHL VAL A 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 3UHL VAL A 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 3UHL ASP A 88 UNP P03367 ASN 588 ENGINEERED MUTATION SEQADV 3UHL THR A 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 3UHL MET A 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 3UHL ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 3UHL LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 3UHL PHE B 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 3UHL VAL B 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 3UHL VAL B 15 UNP P03367 ILE 515 ENGINEERED MUTATION SEQADV 3UHL ASN B 30 UNP P03367 ASP 530 ENGINEERED MUTATION SEQADV 3UHL ILE B 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 3UHL PHE B 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 3UHL ASP B 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 3UHL ILE B 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 3UHL ASN B 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 3UHL VAL B 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 3UHL LEU B 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 3UHL GLU B 58 UNP P03367 GLN 558 ENGINEERED MUTATION SEQADV 3UHL VAL B 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 3UHL PRO B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 3UHL ALA B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 3UHL VAL B 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 3UHL VAL B 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 3UHL ASP B 88 UNP P03367 ASN 588 ENGINEERED MUTATION SEQADV 3UHL THR B 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 3UHL MET B 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 3UHL ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 3UHL LYS C 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 3UHL PHE C 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 3UHL VAL C 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 3UHL VAL C 15 UNP P03367 ILE 515 ENGINEERED MUTATION SEQADV 3UHL ASN C 30 UNP P03367 ASP 530 ENGINEERED MUTATION SEQADV 3UHL ILE C 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 3UHL PHE C 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 3UHL ASP C 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 3UHL ILE C 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 3UHL ASN C 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 3UHL VAL C 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 3UHL LEU C 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 3UHL GLU C 58 UNP P03367 GLN 558 ENGINEERED MUTATION SEQADV 3UHL VAL C 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 3UHL PRO C 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 3UHL ALA C 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 3UHL VAL C 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 3UHL VAL C 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 3UHL ASP C 88 UNP P03367 ASN 588 ENGINEERED MUTATION SEQADV 3UHL THR C 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 3UHL MET C 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 3UHL ALA C 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 3UHL LYS D 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 3UHL PHE D 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 3UHL VAL D 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 3UHL VAL D 15 UNP P03367 ILE 515 ENGINEERED MUTATION SEQADV 3UHL ASN D 30 UNP P03367 ASP 530 ENGINEERED MUTATION SEQADV 3UHL ILE D 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 3UHL PHE D 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 3UHL ASP D 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 3UHL ILE D 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 3UHL ASN D 37 UNP P03367 SER 537 ENGINEERED MUTATION SEQADV 3UHL VAL D 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 3UHL LEU D 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 3UHL GLU D 58 UNP P03367 GLN 558 ENGINEERED MUTATION SEQADV 3UHL VAL D 62 UNP P03367 ILE 562 ENGINEERED MUTATION SEQADV 3UHL PRO D 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 3UHL ALA D 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 3UHL VAL D 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 3UHL VAL D 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 3UHL ASP D 88 UNP P03367 ASN 588 ENGINEERED MUTATION SEQADV 3UHL THR D 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 3UHL MET D 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 3UHL ALA D 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 A 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 B 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 C 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 C 99 PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU SEQRES 6 C 99 ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR SEQRES 8 C 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 D 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE HET SO4 A 101 5 HET SO4 A 102 5 HET 2NC C 101 54 HET SO4 C 102 5 HET SO4 D 101 5 HETNAM SO4 SULFATE ION HETNAM 2NC N-{(2S)-2-[(N-ACETYL-L-THREONYL-L-ISOLEUCYL) HETNAM 2 2NC AMINO]HEXYL}-L-NORLEUCYL-L-GLUTAMINYL-N~5~- HETNAM 3 2NC [AMINO(IMINIO)METHYL]-L-ORNITHINAMIDE HETSYN 2NC P2/NC FORMUL 5 SO4 4(O4 S 2-) FORMUL 7 2NC C35 H68 N11 O8 1+ FORMUL 10 HOH *106(H2 O) HELIX 1 1 GLY A 86 ILE A 93 1 8 HELIX 2 2 GLY B 86 THR B 91 1 6 HELIX 3 3 GLN B 92 GLY B 94 5 3 HELIX 4 4 GLY C 86 GLN C 92 1 7 HELIX 5 5 ARG D 87 THR D 91 1 5 HELIX 6 6 GLN D 92 GLY D 94 5 3 SITE 1 AC1 3 LYS A 43 LYS C 7 ARG D 57 SITE 1 AC2 5 LYS A 43 LYS A 45 MET A 46 TRP D 42 SITE 2 AC2 5 HOH D 202 SITE 1 AC3 23 ASP C 25 GLY C 27 ALA C 28 ASP C 29 SITE 2 AC3 23 ASN C 30 ILE C 32 GLY C 48 ILE C 50 SITE 3 AC3 23 PRO C 81 HOH C 201 HOH C 213 HOH C 214 SITE 4 AC3 23 ASP D 25 GLY D 27 ALA D 28 ASP D 29 SITE 5 AC3 23 ASN D 30 ILE D 32 GLY D 48 ILE D 50 SITE 6 AC3 23 THR D 80 VAL D 82 HOH D 204 SITE 1 AC4 2 LYS C 7 ARG C 8 SITE 1 AC5 5 ARG A 8 PHE A 53 PRO D 44 LYS D 45 SITE 2 AC5 5 MET D 46 CRYST1 63.789 63.789 213.664 90.00 90.00 90.00 P 43 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015677 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015677 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004680 0.00000